TrialAnnals of the rheumatic diseases2020

Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial.

Felix Eckstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.